Format

Send to:

Choose Destination
See comment in PubMed Commons below
Postgrad Med. 2010 Sep;122(5):185-8. doi: 10.3810/pgm.2010.09.2215.

Review of liraglutide versus sitagliptin for patients with uncontrolled type 2 diabetes: more effective HbA 1c reduction with subcutaneous GLP-1 receptor agonist versus an oral DPP-4 inhibitor.

Author information

  • 1HealthReach Diabetes Endocrine Nutrition Center, 881 Lafayette Rd., Hampton, NH 03842, USA. dnadeaumd@gmail.com
PMID:
20861602
[PubMed]

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk